Ignite Creation Date:
2024-05-06 @ 2:00 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01942135
Status:
COMPLETED
Last Update Posted:
2024-04-04
First Post:
2013-09-10
Brief Title:
Palbociclib PD-0332991 Combined With Fulvestrant In Hormone Receptor HER2-Negative Metastatic Breast Cancer After Endocrine Failure PALOMA-3
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-10
First Submit QC Date:
September 10 2013
Study First Post Date:
2013-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-05-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-01
Last Update Post Date:
2024-04-04
Last Update Post Date Type:
ACTUAL